PATENT CLAIM ANALYSIS

Application Number: 15952875
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["514", "451000"]

Abstract:
A  cannabis  based therapeutic product for treatment of chronic pain produced by separating hash resin from plant material of the  cannabis  plant, pressing the hash resin to expel oil, leaving spent hash resin, extracting further cannabinoids from the spent hash resin using MCT oil, separating the  cannabis  compounds from the oils using high pressure liquid chromatography, flash chromatography, or similar techniques, and processing selected  cannabis  compound formulations into a pill, tablet, liquid, or other form suitable for administration as a therapeutic product for treatment of chronic pain, optionally with the further step of enriching the product with a formulation comprising at least 1% by weight purified -myrcene, prior to processing into a final product.

Claim (Index 3):
The method of  claim 1 , wherein the formulation comprises 0.25% w/w to 40% w/w -myrcene, 10% w/w to 20% w/w cannabidiol (CBD), 5% w/w to 15% w/w p-cymene and 15% w/w to 30% w/w borneol.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.80282
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15951154', '15152253', '14216744', '14742503', '14742493']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957708392938717
- 35 USC 102 Novelty (BERT): 0.5111194006735771
- Combined Prediction Score: 0.7673056954318423
- Mean Citation Score: 263.11831
- Max Citation Score: 282.25546
- Similarity Product: 205.36913390748265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test